<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Source Comments</a></li><li><a href="#id2">Reason for Visit</a></li><li><a href="#id3">Encounter Details</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Patient Instructions</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Plan of Treatment</a></li><li><a href="#id8">Visit Diagnoses</a></li><li><a href="#id9">Care Teams</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Source Comments</a></h3><div>In the event this information is protected by the Federal Confidentiality of Alcohol and Drug Abuse Patient Records regulations: This information has been disclosed to you from records protected by Federal confidentiality rules (42 CFR Part 2). The Federal rules prohibit you from making any further disclosure of this information unless further disclosure is expressly permitted by the written consent of the person to whom it pertains or as otherwise permitted by 42 CFR Part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. The Federal rules restrict any use of the information to criminally investigate or prosecute any alcohol or drug abuse patient.Cleveland Clinic</div><h3><a name="id2" href="#toc">Reason for Visit</a></h3><div><ul><li><table><colgroup><col width="25%"/><col width="75%"/></colgroup><thead><tr><th>Reason</th><th>Comments</th></tr></thead><tbody><tr ID="rfv3"><td ID="reasonrfv3">Follow Up</td><td/></tr><tr ID="rfv4"><td ID="reasonrfv4">Established Patient</td><td/></tr></tbody></table></li></ul></div><h3><a name="id3" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter5" class="xRowNormal"><td>[REDACTED]  8:30 AM EDT</td><td ID="encounter5type">Distance Health</td><td><p>Neurology</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], APRN.CNP</p><p>888 W BONNEVILLE</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><content>[REDACTED] disease with dyskinesia and fluctuating manifestations (Primary Dx); <br/>Visual hallucinations</content></td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><table ID="sochist11"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Never</td><td/><td ID="sochist11packsperday"/><td/><td/></tr><tr ID="sochist11smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Yes</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table ID="sdohassess2"><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Area Deprivation Index</th><th>Answer</th><th>Date Recorded</th></tr></thead><tbody><tr ID="sdohassess2pair1"><td ID="sdohassess2pair1ques">National Score (1-100), lower number is lower risk</td><td ID="sdohassess2pair1ans">Not on file</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair2"><td ID="sdohassess2pair2ques">State Score (1-10), lower number is lower risk</td><td ID="sdohassess2pair2ans">Not on file</td><td>[REDACTED]</td></tr><tr ID="sdohassess2pair3"><td ID="sdohassess2pair3ques">Data from:  https://www.neighborhoodatlas.medicine.wisc.edu/. Last address used for calculation</td><td ID="sdohassess2pair3ans">Not on file</td><td>[REDACTED]</td></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex14"><td>Sex Assigned at Birth</td><td ID="BirthSex14Value">Not on file</td><td/></tr><tr ID="GenderIdentity12"><td>Gender Identity</td><td ID="GenderIdentity12Value">Not on file</td><td/></tr><tr ID="SexualOrientation13"><td>Sexual Orientation</td><td ID="SexualOrientation13Value">Straight</td><td>[REDACTED]  6:38 PM EDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id5" href="#toc">Patient Instructions</a></h3><div><ul><li>Patient Instructions: <ul><li><p> <span class="xLabel">[REDACTED], APRN.CNP - [REDACTED] 10:08 AM PDT</span></p><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>Medication changes as follow: <br/>Take Rytary 245 mg 2 capsules 5/day <br/>Add Rytary 95 mg 1 capsule to each dose of Rytary 245 mg, total 5/day. <br/><br/>[REDACTED] Medications Schedule:<br/> 6 AM 10 AM 2 PM 6 PM 10 PM <br/>Rytary 245 mg 2 2 2 2 2 <br/>Rytary 95 mg   1 1 1 1 1  <br/>Xadago 100 mg 0 1 0 0 0 <br/>Nuplazid 34 mg  1     <br/>Quetiapine 25 mg      1 <br/><br/>Discussed potential side effects with adjustment in medications, may potentially worsen hallucinations. <br/>Recommend telephone virtual visit follow up 3 weeks to reevaluate hallucinations. <br/>Discussed advance therapy with Duopa, levodopa intestinal gel: <br/>https://www.duopa.com/resources?cid=ppc_ppd_ggl_duopa_branded_2020_duopa_Phrase<br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], APRN.CNP at [REDACTED]  1:08 PM EDT</span><br/><br/></li></ul></li></ul>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], APRN.CNP - [REDACTED]  8:29 AM PDT: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>CNR-MOVEMENT DISORDERS CENTER - FOLLOW UP EVALUATION<br/><br/>I had the pleasure of seeing [REDACTED] for follow up [REDACTED].   He is a [REDACTED] right-handed gentleman with a history of PD (2012). <br/><br/>The following A/P was developed at the previous visit: <br/>For your ear symptoms, you can try to irrigate your ear twice per week and start zyrtec 5 mg 1 tab once daily. <br/>Discuss with your primary care provider and consult if you need a referral to ENT (Ear, Nose, Throat) specialist. <br/>Medications - Maintain Rytary 245 mg 2 caps 5/day + Xadago 100 mg 1 tab once daily. <br/>For your OFF times, you can take an additional C/L 1/2 tab between 2 - 6 p as needed. <br/>Maintain the Parcopa 10/100 mg 1/2 tab 4/day (9a, 1p, 5p, 9p). <br/>Discussed DBS, you are not interested at this time. <br/>Discussed trial of Nourianz extender. <br/>Follow up 6 months or sooner if needed. <br/><br/>Interval History Since Last Visit:  <br/><br/>UPDATE [REDACTED]:<br/>The patient was last seen [REDACTED].  This is a telephone visit with consent obtained from the patient and/or caregiver.  <br/><br/>I have communicated my name and active licensure. The patient's identity and physical location were verified at the time of this visit. Either the patient or their legal representative has been informed of the risks and benefits of -- and alternatives to -- treatment through a remote evaluation and consents to proceed with the evaluation remotely.<br/><br/>He is reporting that magnesium helps. He stopped it and had noticeably worse cramps. <br/>He takes parcopa 1/2 tab at 9a, 1p, 5p, 9p within 30 min before Rytary this help the wearing off. <br/>He has afternoon OFF times, usually between 2 - 6p, it can be any time during this period. <br/>He remain with hallucinations in the evening and now occasionally during the day. Has insight. Overall improved on Nuplazid. <br/>His weight has been maintaining. <br/>He is working out with heavier weights and gaining muscle back.  <br/>He will occasional have the paresthesia in the feet but less consistent when he is ON. <br/>He has a mild pressure/popping sensation in the L ear that he feels may be interfering with balance. <br/><br/>He describes worsening of shuffling. The additional dose of Parcopa has really helped. <br/>He is seeing his calves cramp up more, taking 400 mg 1 tab per day.<br/>He gets tired every day around 2p and will take a short nap. <br/>He describes decrease stamina in the evening, he has freezing, not every night but some nights. <br/><br/>[REDACTED] Medications Schedule:<br/> 6 AM 10 AM 2 PM 6 PM 10 PM <br/>Rytary 245 mg 2 2 2 2 2 <br/>Parcopa 10/100 mg   1/2 tab 9 1/2 tab 1p [REDACTED] tab 5p [REDACTED] tab 9p <br/>Xadago 100 mg 0 1 0 0 0 <br/>Nuplazid 34 mg  1     <br/>Quetiapine 25 mg      1 <br/> <br/>Allergies: <br/> ALLERGIES<br/>Not on File<br/><br/>Current Medications: <br/>Current Outpatient Medications <br/>Medication Sig <br/> XADAGO 100 mg tab take 1 tablet by mouth every day <br/> carbidopa-levodopa (RYTARY) 61.25-245 mg capsule TAKE 2 CAPSULES BY MOUTH AT 6 AM AND 2 CAPSULES AT 10 AM, 2 CAPSULES AT 3 PM, 3 CAPSULES AT 5 PM AND 2 CAPSULES AT 10 PM <br/> QUEtiapine (SEROQUEL) 25 mg tablet Take 1 tablet by mouth daily at bedtime. <br/> pimavanserin (NUPLAZID) 34 mg Take 1 capsule by mouth daily at bedtime. <br/> carbidopa-levodopa orally-disintegrating (PARCOPA) 10-100 mg per disintegrating tablet Take 1 tablet by mouth twice daily (10AM, 10PM) <br/> MAGNESIUM ORAL Take by mouth once daily. <br/> lisinopril (ZESTRIL, PRINIVIL) 10 mg tablet Take 10 mg by mouth once daily. <br/> <br/><br/>No current facility-administered medications for this visit. <br/> <br/>Objective:<br/>Vital Signs: <br/>There were no vitals taken for this visit.<br/><br/>MDS-UPDRS [REDACTED] <br/>MDS-UPDRS MEDICATION OFF/ON ON <br/>MDS-UPDRS TIME of UPDRS 33180 <br/>MDS-UPDRS TIME OF LAST MEDICATION 21600 <br/>MDS-UPDRS LAST MEDICATION TAKEN Rytary 245 mg 2 caps <br/>MDS-UPDRS DBS-RIGHT (UPDRS) N/A <br/>MDS-UPDRS DBS-LEFT (UPDRS) N/A <br/>SPEECH 0 <br/>FACIAL EXPRESSION 1 <br/>RIGIDITY NECK 0 <br/>RIGIDITY RUE 1 <br/>RIGIDITY [REDACTED] 0 <br/>RIGIDITY RLE 0 <br/>RIGIDITY LLE 0 <br/>FINGER TAPS RT 1 <br/>FINGER TAPS LT 1 <br/>HAND MOVES RT 1 <br/>HAND MOVES LT 0 <br/>PRONATE/SUPINATE RT 0 <br/>PRONATE/SUPINATE LT 0 <br/>TOE TAPS RT 0 <br/>TOE TAPS LT 0 <br/>LEG AGILITY RT 0 <br/>LEG AGILITY LT 0 <br/>ARISE FR CHAIR 0 <br/>GAIT 0 <br/>GAIT FREEZE 0 <br/>POSTURE STABILITY 0 <br/>POSTURE 0 <br/>BODY BRADYKINESIA 0 <br/>POSTURAL TREMOR HAND RT 0 <br/>POSTURAL TREMOR HAND LT 0 <br/>KINETIC TREMOR RT 0 <br/>KINETIC TREMOR LT 0 <br/>REST TREMOR AMP RUE 0 <br/>REST TREMOR AMP [REDACTED] 0 <br/>REST TREMOR AMP RLE 0 <br/>REST TREMOR AMP LLE 0 <br/>REST TREMOR AMP LIP/JAW 0 <br/>REST TREMOR CONSTANT 0 <br/>MDS-UPDRS LEFT TOTAL 1 <br/>MDS-UPDRS RIGHT TOTAL 3 <br/>MDS-UPDRS MIDLINE TOTAL 1 <br/>MDS-UPDRS TREMOR TOTAL/40 0 <br/>MDS-UPDRS PIGD TOTAL/12 0 <br/>MDS-UPDRS OVERALL TOTAL 5 <br/><br/>Based on [REDACTED] exam the patient is [REDACTED] and [REDACTED] stage 2 (Mild to moderate bilateral disease; physically independent).<br/><br/>Assessment and Plan: <br/>[REDACTED] is a right-handed [REDACTED] gentleman with idiopathic [REDACTED] disease complicated by motor fluctuations, wearing off cramping, neuropathy, and gait disturbance. He is also reporting hallucinations with insight. He is exhibiting limitations to dopamine therapy, as higher doses may potentially worsen the psychosis. [REDACTED], we discussed the alternative medication replacement options for Parcopa as it is no longer available. We discussed replacing Parcopa with C/L IR, but due to the medication burden, will first start with Rytary 245 mg (2 capsules) + Rytary 95 (1 capsule) 5 times daily. <br/><br/> <br/>The following are the current problems noted and addressed during this visit:<br/>[REDACTED] disease with dyskinesia and fluctuating manifestations  (primary encounter diagnosis)<br/>Visual hallucinations<br/><br/>Level of service: Est level 4 (30-39 min). Time spent 35 min on the day of service, which included preparing to see the patient, completing clinical documentation, counseling and educating the patient/family/caregiver, ordering medications, tests, or procedures, and care coordination (not separately reported).<br/><br/>Plan:<br/>  <br/>Medication changes as follow: <br/>Take Rytary 245 mg 2 capsules 5/day <br/>Add Rytary 95 mg 1 capsule to each dose of Rytary 245 mg, total 5/day. <br/><br/>[REDACTED] Medications Schedule:<br/> 6 AM 10 AM 2 PM 6 PM 10 PM <br/>Rytary 245 mg 2 2 2 2 2 <br/>Rytary 95 mg   1 1 1 1 1  <br/>Xadago 100 mg 0 1 0 0 0 <br/>Nuplazid 34 mg  1     <br/>Quetiapine 25 mg      1 <br/><br/>Discussed potential side effects with adjustment in medications, may potentially worsen hallucinations. <br/>Recommend telephone virtual visit follow up 3 weeks to reevaluate hallucinations. <br/>Discussed advance therapy with Duopa, levodopa intestinal gel: <br/>https://www.duopa.com/resources?cid=ppc_ppd_ggl_duopa_branded_2020_duopa_Phrase<br/><br/>Return in about 3 weeks (around [REDACTED]) for Virtual Visit.<br/><br/>[REDACTED], DNP, FNP-C <br/>Nurse Practitioner, Movement Disorders Clinic<br/>[REDACTED] [REDACTED][REDACTED][REDACTED] for Brain Health <br/>[REDACTED][REDACTED][REDACTED]<br/>Office: [REDACTED]<br/>Fax: [REDACTED] <br/></content><br/><span class="xLabel">Electronically signed by [REDACTED], APRN.CNP at [REDACTED]  1:10 PM EDT</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter34" class="xRowNormal"><td>[REDACTED]  1:30 PM EDT</td><td ID="encounter34type">Distance Health</td><td><p>Neurology</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], APRN.CNP</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><span class="content_span">[REDACTED]</span></td></tr><tr ID="encounter33" class="xRowAlt"><td>[REDACTED] 11:30 AM EST</td><td ID="encounter33type">Office Visit</td><td><p>Neurology</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], APRN.CNP</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td><span class="content_span">Return in about 6 months (around [REDACTED]).</span></td></tr></tbody></table>documented as of this encounter</div><h3><a name="id8" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx6" class="xRowNormal"><td><p><span class="content_span">[REDACTED] disease with dyskinesia and fluctuating manifestations (HCC)</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx7" class="xRowAlt"><td><p><span class="content_span">Visual hallucinations</span></p><p>Psychophysical visual disturbances</p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id9" href="#toc">Care Teams</a></h3><div><table ID="ct45"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>[REDACTED] L</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>Suite 140</p><p>[REDACTED], NV 89052-4372</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><br/><br/>
</body></html>